SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hauser WA. Epidemiology of seizures in the elderly. In: RowanAJ, RamsayRE, eds. Seizures and epilepsy in the elderly. Newton, MA: Butterworth-Heinemann, 1997: 720.
  • 2
    Hauser WA, Annegers JK, Kurland LT. The incidence of epilepsy in Rochester, Minnesota, 1935-1984. Epilepsia 1993;34: 4539.
  • 3
    Willmore LJ. Management of epilepsy in the elderly. Neurol Clin 1996;11: 787804.
  • 4
    Craig I & Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994;35: 38190.
  • 5
    Meador KJ, Loring DW, Moore EE, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45: 14949.
  • 6
    Reynolds EJ & Trimble MR. Adverse neuropsychiatric effects of antiepileptic drugs. Drugs 1985;29: 57081.
  • 7
    Leach JP, Girvan J, Paul A, et al. Gabapentin and cognition: a double-blind, dose-ranging, placebo-controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997;62: 3726.
  • 8
    Morris GL. Use of gabapentin in patients over 50 years of age [Abstract]. J Epilepsy 1996;9: 144.DOI: 10.1016/0896-6974(96)85620-9
  • 9
    Faught E. Epidemiology and drug treatment of epilepsy in elderly people. Drugs Aging 1999;15: 25569.
  • 10
    Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40: 127985.
  • 11
    Read CL, Stephen LJ, Stolarek IH, et al. Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study. Seizure 1998;7: 15962.
  • 12
    Wechsler D. Wechsler Memory Scale–Revised. New York: Psychological Corporation, 1987.
  • 13
    Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. 2nd ed. Philadelphia: Lea & Febiger, 1983.
  • 14
    Benton AL & Hamsher DdeS. Multilingual aphasia examination. Iowa City, IA: AJA Associates, 1983.
  • 15
    Lezak M. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1995.
  • 16
    Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52: 3217.
  • 17
    Meador KJ, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41: 153740.
  • 18
    Smith A. Symbol digit modalities test manual. Los Angeles: Western Psychological Services, 1973.
  • 19
    Buschke H & Fuld PA. Evaluation storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24: 101925.
  • 20
    Gronwall D & Wrightson P. Delayed recovery of intellectual function after minor head injury. Lancet 1974;2: 20710.
  • 21
    McNair DM, Lorr, M, Droppleman LF. Manual: profile of mood states-revised. San Diego, CA: Educational and Industrial Testing Service, 1992.
  • 22
    Cohen H, Howland MA, Luciano DJ, et al. Feasibility and pharmacokinetics of carbamazepine oral loading doses. Am J Health Syst Pharm 1998;55: 113440.
  • 23
    Kanner AM, Bourgeois BF, Hasegawa H, et al. Rapid switchover to carbamazepine using pharmacokinetic parameters. Epilepsia 1998;39: 194200.
  • 24
    Pullianen V & Jokelainen M. Effects of phenytoin and carbamazepine on cognitive functioning. Acta Neurol Scand 1994;89: 816.
  • 25
    Harden CL, Lazar LM, Pick LH, et al. A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999;40: 112934.
  • 26
    Handforth A & Treiman DM. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations. Epilepsia 1994;35: 10327.
  • 27
    Bennett J, Goldman WT, Suppes T. Gabapentin in the treatment of bipolar and schizoaffective disorders. J Clin Psychopharmacol 1997;17: 1412.DOI: 10.1006/geno.1993.1295
  • 28
    Schaffer CB & Schaffer LC. Gabapentin for the treatment of bipolar disorder [Letter]. Am J Psychiatry 1997;154: 291.
  • 29
    Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications. In: WyllieE, ed. The treatment of epilepsy: principles and practice. 2nd ed. Baltimore: Williams & Wilkins, 1996: 112130.
  • 30
    Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37: 817.DOI: 10.1016/s0920-1211(99)00039-x
  • 31
    United States General Accounting Office. Prescription drugs and the elderly. GAO/HEHS-95-152, 1995.
  • 32
    Cameron H & Macphee GJA. Anticonvulsant therapy in the elderly: a need for placebo controlled trials. Epilepsy Res 1995;21: 14957.DOI: 10.1016/0920-1211(95)00016-4
  • 33
    Mattson RH. New antiepileptic drugs: from discovery to practical use. Epilepsia 1996;(suppl 6);37.
  • 34
    Elphick, M. Clinical issues in the use of carbamazepine in psychiatry: a review. Psychol Med 1989;19: 591604.
  • 35
    Beydoun A, Fischer J, Labor DR, et al. Gabapentin monotherapy II: a 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. Neurology 1997;49: 74652.
  • 36
    Radulovic LL, Wilder BJ, Leppik IE, et al. Lack of interaction of gabapentin with carbamazepine or valproate. Epilepsia 1994;35: 15561.